Amish Chaturvedi is an experienced market access professional with 26 years of experience in the Pharmaceutical industry including in Pricing, Market access, Reimbursement and Policy across EU and JAPAC region. At EVERSANA, he leads Pricing and Market Access practice for the APAC region. As a practice lead, Amish leverages his vast experience to support pharmaceutical, medical devices and biotech companies build Value and Access strategy for Asia-Pacific region including for key markets like Japan, China, India, South Korea, Taiwan and Australia. Amish has extensive experience in developing and optimizing value communication in the local context to improve relevance and impact on payers. In addition, Amish supports clients optimize their access and reimbursement strategies at a regional level and guides the development of HTA submissions at country level.   Prior to joining EVERSANA, Amish spent 15 years in Policy and Market Access functions as therapy area lead for Abbvie and Janssen in above country and affiliate level roles.  Amish has hands-on experience managing reimbursement submissions to multiple HTA agencies. He has a deep understanding of access policies in key European and Asia-Pacific markets and HTA requirements across JAPAC,EU4 and the UK. He has worked across multiple therapy areas including Oncology, Immunology, Neuroscience, Infectious Diseases and Vaccines. Amish holds a B-Pharm degree, MBA degree (Australian National University) and Health Economics degree from London School of Economics (LSE).

Andrew’s Career in Healthcare spans 35 years. In his current role Andrew has responsibility for Healthcare Policy, supporting AWS public policy teams across the APAC region Previously Andrew led the Health Economics, Market Access, Policy and Government and Stakeholder Relations functions for Medtronic in Australia and New Zealand, in addition to coordinating Government Affairs for the APAC region. Before that Andrew had a variety of roles within Healthcare organisations across business and functional leadership. In addition to his Medtech experience, Andrew started his career as a Registered Nurse and has worked in the Pharmaceutical Industry as well as a brief stint in the Hospitality Industry. He holds an MBA from the University of New England and a BA in Media from Griffith University. He is an ARCS Australia Board Member and is Chair of the MTAA Digital Health Advisory Group and Co-Chair of the US-ASEAN Business Council Digital Health Committee.

Lyn was appointed as Managing Director of Tunstall Healthcare for Asia Pacific in 2011. Tunstall Healthcare is a world-leading provider of Connected Care and Connected Health solutions. Tunstall operates in 18 countries around the world, with 235 Monitoring Centres supporting over 5 million people. Their products and solutions play a key role in helping older people, and those with long-term health needs, to live safely and independently in a place of their choice. Lyn joined Tunstall in 2004 with 20 years’ of experience in 24/7 operations and service delivery across the public and private sectors. Prior to working for Tunstall she held leadership positions for the Qld Mater Hospitals and for CITEC, the information technology division for the State of Queensland. Lyn is a strong advocate for consumers and industry and an active member and director on key industry groups. She is currently a member the Medical Technology Association of Australia (MTAA). Lyn is also a Director and Deputy Chair of the Personal Emergency Response Service Limited (PERSL). Personal Emergency Response Services Limited (PERSL) is a self-governing body that represents manufacturers, service providers, and consumers of Personal Emergency Response Systems.